Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

September 26, 2016September 26, 2016

Inventiva Receives €2.3 Million to Support YAP/TEAD Protein Research Program

Lung Cancer, News

Inventiva has been awarded two grants totaling €2.3 million ($2.58 million) to further its YAP/TEAD protein research program, which focuses on developing molecules with the potential to treat severe forms of lung, ... Read more

September 22, 2016September 22, 2016

Researchers Identify Circulating Immune Cells as Potential IPF Biomarkers

Idiopathic Pulmonary Fibrosis, News

Researchers in Germany discovered that patients with idiopathic pulmonary fibrosis (IPF) have increased levels of myeloid-derived suppressor cells (MDSC) in the blood. The higher the number of MDSC, the more limited ... Read more

September 14, 2016September 14, 2016

Boehringer Reports Long-term Positive Effects of IPF Therapy Ofev

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim recently shared positive data from a clinical trial evaluating long-term treatment with Ofev (nintedanib) in idiopathic pulmonary fibrosis (IPF) patients. The interim findings from the INPULSIS-ON extension trial were ... Read more

September 12, 2016September 12, 2016

Portable Breathalyzer for Asthma Diagnosis and Management Approved in Europe

Asthma, News

Spirometrix, a medical device company focused on breath analysis devices for the diagnosis and management of asthma, recently announced that its Fenom PRO Point-of-Care Breathalyzer has received CE marking and will now be commercially ... Read more

September 6, 2016September 6, 2016

Philips Sponsoring Film on Leonard Nimoy and His Final Struggle with COPD

COPD, News

Royal Philips is sponsoring a new documentary, “COPD: Highly Illogical – Remembering Leonard Nimoy,“ which provides an intimate look at the actor’s life, legacy, and his final years confronting chronic obstructive pulmonary disease ... Read more

August 23, 2016August 23, 2016

Cinqaero (Reslizumab) for Severe Asthma Granted EC Marketing Authorization

Asthma, News

The European Commission (EC) has granted marketing authorization for Teva Pharmaceutical’s Cinqaero (reslizumab) in all European Union (EU) nations, Norway, Liechtenstein, and Iceland. The therapy treats inadequately controlled asthma in adult and ... Read more

August 22, 2016August 22, 2016

FDA Grants Orphan Drug Status to Pulmatrix’s PUR1900 for Cystic Fibrosis Fungal Lung Infections

Cystic Fibrosis, News

The U.S. Food & Drug Administration (FDA) has granted orphan drug designation to Pulmatrix‘s PUR1900, an inhaled drug for the treatment of pulmonary fungal infections in patients with cystic fibrosis (CF). ... Read more

August 15, 2016

Gene Based Diagnostic Tool for Rare Forms of Pulmonary Hypertension Developed by Researchers

News

A team of pulmonology and genetics specialists at the Intermountain Medical Center and ARUP Laboratories in Salt Lake City, Utah, jointly developed a diagnostic genomic testing method for rare forms of ... Read more

August 12, 2016August 12, 2016

Better Combination Therapy Appears More Effective for COPD Exacerbations, Study Finds

COPD, News

Results from a recent clinical trial demonstrated that treatment with the combination bronchodilator and inhaled medicine therapy indacaterol/glycopyrronium is better for treating chronic obstructive pulmonary disorder (COPD) exacerbations. The study, ... Read more

August 10, 2016August 10, 2016

NIH Grants $4.2M to New York Pediatrician to Study Asthma Management in Children

Asthma

A $4.2 million grant from the National Institutes of Health (NIH) was recently awarded to attending physician Dr. Marina Reznik at The Children’s Hospital at Montefiore in the Bronx, New York City, ... Read more